InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Raffin Thomas A., Director. Officer active across 3 companies, notably Lumos Pharma, INC.. Aggregated, 5 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €103k. History available since 20 May 2021. The latest transaction was filed on 12 June 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
9,406 sharesCommon StockSEC:0001126234-24-000117:0
20,000 shares@ US$5.00100.0% of flowCommon StockSEC:0001104659-23-070479:0
Ideal exit: 8 Mar 2024 (T+270)
1,150 shares@ US$8.46100.0% of flowCommon StockSEC:0001126234-22-000093:0
Ideal exit: 22 May 2023 (T+270)
367 shares0Common StockSEC:0001126234-21-000082
367 shares0Common StockSEC:0001126234-21-000082:0
5 of 5 declarations
About Raffin Thomas A.
Thomas A. Raffin is a Director at Lumos Pharma, Inc. In this role, he participates in the governance of the company and strategic decision-making. Thomas brings expertise in management and business development, helping to guide growth initiatives. His commitment to integrity and efficiency is an asset to the board.
